Kennametal (KMT) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
9 Jul, 2026Executive summary
Q2 FY25 sales were $482M, down 3% year-over-year with a 6% organic decline, driven by weaker EMEA and U.S. markets, partially offset by Aerospace & Defense growth and favorable business days.
EPS was $0.23 (adjusted $0.25), both below prior year; margins improved due to cost actions, lower raw material costs, and insurance recoveries.
Announced plant closures and workforce reductions targeting $15M annualized pre-tax savings by FY25 end, with $25M in related pre-tax charges.
Returned $31M to shareholders in Q2 via $15M in share repurchases and $16M in dividends.
Full-year outlook lowered due to continued market softness, especially in EMEA.
Financial highlights
Q2 sales were $482M, down 3% reported and 6% organic year-over-year; gross profit was $145M (30.1% margin), up from $139.6M (28.2%).
Adjusted EBITDA margin rose to 13.9% from 12.4% year-over-year; adjusted EPS fell to $0.25 from $0.30.
Operating income was $32M (6.6% margin), up from $28M (5.7% margin); adjusted operating income was $33M (6.9% margin).
Operating cash flow YTD was $101M, up from $88M; free operating cash flow YTD increased to $57M from $36M.
Capital expenditures for the six months were $44M, down from $57.5M year-over-year.
Outlook and guidance
Q3 sales expected at $480M–$500M, with adjusted EPS forecasted at $0.20–$0.30 and a 3% FX headwind.
FY25 sales outlook revised to $1.95B–$2.0B; adjusted EPS expected at $1.05–$1.30; free operating cash flow projected to exceed 125% of adjusted net income.
Capital spending for FY25 expected at $100M; adjusted effective tax rate for FY25 expected at 27.5%.
End-market outlook: Aerospace & Defense to see slight growth; all other segments expected to decline or be flat.
Ongoing cost reduction initiatives to address softer market conditions, especially in EMEA.
Latest events from Kennametal
- Adjusted EPS rose to $0.47 despite a 6% sales decline, aided by credits and cost actions.KMT
Q3 20258 Jul 2026 - Q3 sales and margins surged on price, volume, and tungsten dynamics; FY26 outlook raised.KMT
Q3 20266 May 2026 - Q2 sales and margins surged, prompting raised full-year guidance and continued strong outlook.KMT
Q2 202613 Apr 2026 - Q4 delivered margin gains and strong cash flow; FY25 outlook signals stable, cautious growth.KMT
Q4 20242 Feb 2026 - Sales and margins declined, but cash flow and shareholder returns improved.KMT
Q1 202516 Jan 2026 - Annual meeting to vote on directors, auditor, executive pay, and new incentive plan.KMT
Proxy Filing1 Dec 2025 - Board recommends approval of all 2025 proxy proposals, emphasizing pay-for-performance and ESG.KMT
Proxy Filing1 Dec 2025 - Virtual annual meeting to vote on directors, auditor, pay, and incentive plan.KMT
Proxy Filing1 Dec 2025 - Election of directors, auditor ratification, and say-on-pay up for vote at virtual annual meeting.KMT
Proxy Filing1 Dec 2025